The U.S. Census Bureau, in collaboration with five federal agencies, launched the Household Pulse Survey to produce data on the social and economic impacts of Covid-19 on American households. The Household Pulse Survey was designed to gauge the impact of the pandemic on employment status, consumer spending, food security, housing, education disruptions, and dimensions of physical and mental wellness.

The survey was designed to meet the goal of accurate and timely weekly estimates. It was conducted by an internet questionnaire, with invitations to participate sent by email and text message. The sample frame is the Census Bureau Master Address File Data. Housing units linked to one or more email addresses or cell phone numbers were randomly selected to participate, and one respondent from each housing unit was selected to respond for him or herself. Estimates are weighted to adjust for nonresponse and to match Census Bureau estimates of the population by age, gender, race and ethnicity, and educational attainment. All estimates shown meet the NCHS Data Presentation Standards for Proportions,

The Research and Development Survey (RANDS) is a series of cross-sectional surveys from probability-sampled commercial survey panels. As part of a special iteration of RANDS that focuses on COVID-19, RANDS during COVID-19 Round 2 is the second round of a three-round survey. In addition to the probability sample of RANDS during COVID-19 Round 2, the questionnaire was administered to the Dynata non-probability online opt-in sample by NORC at the University of Chicago (NORC) from August 3, 2020 to August 20, 2020. The RANDS during COVID-19 Round 2 Non-Probability Sample does not have a known survey sampling design and cannot be used to produce nationally or sub-nationally representative estimates.

The Research and Development Survey (RANDS) is a series of cross-sectional
surveys from probability-sampled commercial survey panels which began in 2015.
RANDS 2 was administered by Gallup using the Gallup Panel in the spring of 2016
and contains existing questions from the National Health Interview Survey (NHIS)
as well as embedded probe questions for cognitive evaluations.

The Research and Development Survey (RANDS) is a series of cross-sectional surveys from probability-sampled commercial survey panels. As part of a special iteration of RANDS that focuses on COVID-19, RANDS during COVID-19 Round 2 is the second round of a three-round survey. The probability sample of RANDS during COVID-19 Round 2 was recruited using NORC at the University of Chicago (NORC)'s AmeriSpeak Panel, and the survey was administered by NORC from August 3, 2020 to August 20, 2020. The RANDS during COVID-19 Round 2 Probability Sample has a known survey sampling design and can be used to produce nationally and sub-nationally representative estimates

The National Epidemiologic Survey on Alcohol and Related Conditions - III (NESARC-III) is a nationally representative survey of 46,500 adult Americans that collected data on alcohol use disorders and their associated disabilities in addition to collecting saliva samples for the purpose of understanding the prevalence, risk factors, health disparities, economic costs and gene-environment interactions related to alcohol use disorders and their associated disabilities.

Results from the study are not yet available. The data collection is also associated with clinical trial number: NCT01273220.

The Research and Development Survey (RANDS) is a series of cross-sectional surveys using probability-sampled commercial survey panels. The fourth round of RANDS (RANDS 4) was administered by NORC at the University of Chicago using the AmeriSpeak Panel from July 17, 2020 to August 24, 2020. RANDS 4 contained the embedded probe questions and experiments as in previous rounds of RANDS, but had an emphasis on disability and the use of opioid pain relievers. RANDS 4 has a known survey sampling design and can be used to produce nationally and sub-nationally representative estimates.

The Research and Development Survey (RANDS) is a series of cross-sectional surveys from probability-sampled commercial survey panels. As part of a special iteration of RANDS that focuses on COVID-19, RANDS during COVID-19 Round 1 is the first round of a three-round survey. The probability sample of RANDS during COVID-19 Round 1 was recruited using NORC at the University of Chicago (NORC)'s AmeriSpeak Panel, and the survey was administered by NORC from June 9, 2020 to July 6, 2020. The RANDS during COVID-19 Round 1 Probability Sample has a known survey sampling design and can be used to produce nationally and sub-nationally representative estimates.

The Research and Development Survey (RANDS) is a series of cross-sectional surveys from probability-sampled commercial survey panels. As part of a special iteration of RANDS that focuses on COVID-19, RANDS during COVID-19 Round 1 is the first round of a three-round survey. In addition to the probability sample in RANDS during COVID-19 Round 1, the questionnaire was administered to the Dynata non-probability online opt-in sample by NORC at the University of Chicago (NORC) from June 9, 2020 to June 30, 2020. The RANDS during COVID-19 Round 1 Non-Probability Sample does not have a known survey sampling design and cannot be used to produce nationally or sub-nationally representative estimates.

The Research and Development Survey (RANDS) is a series of cross-sectional surveys from probability-sampled commercial survey panels. As part of a special iteration of RANDS that focuses on COVID-19, RANDS during COVID-19 Round 3 is the third round of a three-round survey. The sampled participants of RANDS during COVID-19 Round 3 were recruited using NORC at the University of Chicago (NORC)’s AmeriSpeak Panel, and the survey was administered by NORC from May 17, 2021 to June 30, 2021. RANDS during COVID-19 Round 3 has a known survey sampling design and can be used to produce nationally and sub-nationally representative estimates.

National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) was designed to assess the prevalence of alcohol use disorders (AUD) and their associated disabilities in the general population. The survey is the largest ever comorbidity study of multiple mental health disorders among U.S. adults, including alcohol and other substance use disorders, personality disorders, and anxiety and mood disorders. NESARC is designed to be a longitudinal survey with the first wave fielded in 2001–2002. The second wave of interviews was completed in 2004–2005 and used the same sample of respondents.

NESARC is a nationwide household survey with a probability sample representative of US adults. The final sample for Wave 1 was 43,093 respondents; Wave 2 was 34,653 of the Wave 1 respondents.

Data are not publicly available; however, researchers may request specific analyses via Census.